Immunology
-
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters
This article has 35 authors:Reviewed by ScreenIT
-
Neutralization Of SARS-CoV-2 Variants By A Human Polyclonal Antibody Therapeutic (COVID-HIG, NP-028) With High Neutralizing Titers To SARS-CoV-2
This article has 1 author:Reviewed by ScreenIT
-
Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release
This article has 3 authors:Reviewed by ScreenIT
-
Omicron BA.2 specifically evades broad sarbecovirus neutralizing antibodies
This article has 41 authors:Reviewed by ScreenIT
-
Circulatory exosomes from COVID-19 patients trigger NLRP3 inflammasome in endothelial cells
This article has 5 authors:Reviewed by ScreenIT
-
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron
This article has 66 authors:Reviewed by ScreenIT
-
Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures
This article has 14 authors:Reviewed by ScreenIT
-
CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
This article has 6 authors:Reviewed by ScreenIT
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine
This article has 16 authors:Reviewed by ScreenIT
-
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
This article has 22 authors:Reviewed by ScreenIT